CRANBURY, N.J.--(BUSINESS WIRE)--Physicians’ Education Resource® (PER®), a worldwide leading resource for continuing medical education (CME), will present its ASCO Direct™ Highlights Saturday, June 22, at the Westin Kansas City at Crown Center in Missouri. The program will be co-chaired by Dr. Suman Kambhampati, co-medical director of the blood cancer program at Sarah Cannon Cancer Institute HCA Midwest Health, and Dr. Stephanie L. Graff, director of the breast cancer program at Sarah Cannon Cancer Institute HCA Midwest Health and associate director of the breast cancer research program at Sarah Cannon Research Institute.
“We are so pleased to offer this single-day, exciting program to oncologists, nurses and pathologists across the county to learn about top practice-changing data in clinical oncology,” said Phil Talamo, president of PER®. “Our goal is to expand our attendees’ knowledge of evolving therapeutic paradigms for patients with solid tumors or hematologic malignancies and improve their ability to select therapeutic options based on patient and tumor characteristics.”
ASCO Direct™ Highlights is a one-day program designed to provide medical and surgical oncologists, as well as nurses and pathologists, with key practice-changing data from the premier clinical oncology event in North America. The top abstracts in solid tumors, including thoracic, breast, gastrointestinal, genitourinary, gynecologic, and dermatologic malignancies, will be featured. The top abstracts presented in hematologic malignancies will also be discussed. In addition, extended time will be devoted to discussing the top abstracts from the overall American Society of Clinical Oncology meeting, including the plenary session.
For more information and to register, click here.
About Physicians’ Education Resource® (PER®)
Since 1995, PER® has been dedicated to advancing cancer care through professional education and now furthers patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER® initiated continuing medical education (CME) programming in the cardiovascular and endocrinology areas. While continuing to expand into topics outside of oncology, PER® remains the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature leading distinguished experts who focus on the application of practice-changing advances. PER® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER® is part of the Cranbury, New Jersey-based MJH Associates, Inc., family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com.
